Weill Cornell Medicine-NY

Infusion of vascular cells to treat liver cirrhosis shows promise

A new therapy that uses blood-vessel-lining cells to regenerate damaged tissue has the potential to treat liver cirrhosis.

Parasitic disease linked to HIV infection

Women diagnosed with an infectious parasitic disease prevalent in sub-Saharan Africa are at increased risk of contracting HIV.

Cornell, community partners reflect on engagement for the greater good

Provost Michael Kotlikoff led a panel of faculty and community partners Oct. 20 to discuss the benefits of collaborative work and community efforts engaging students in addressing local and global public health challenges.

Symposium fosters entrepreneurial spirit at Weill Cornell Medicine

The Dean’s Inaugural Symposium on Opportunities for Entrepreneurship and Academic Drug Development was held Oct. 9 at Weill Cornell Medicine.

Weill Cornell Medicine researcher wins Lupus Insight Prize

Dr. Virginia Pascual was awarded the Lupus Insight Prize June 15 by the Lupus Research Alliance.

Menopause triggers changes in brain that may promote Alzheimer’s

Menopause causes metabolic changes in the brain that may increase the risk of Alzheimer’s disease, a research team says.

Group uses organoid to explain immune cells’ rapid response

A team led by researchers from Cornell's Ithaca and New York City campuses has used a tool it developed to explain an immune system process. The work could benefit cancer research.

Weill Cornell Medicine awarded $45.3M NIH grant

Weill Cornell Medicine has received a $45.3 million renewal grant from the National Institutes of Health’s Clinical and Translational Science Awards Program.

Cornell Tech leverages academic links with Cornell campuses

The new Roosevelt Island campus of Cornell Tech has catalyzed a slew of innovative academic programs that will benefit not only Cornell Tech students but also students from the Ithaca campus.